Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MSn techniques
- 4 December 2014
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 407 (5) , 1371-1388
Abstract
5-APB (5-(2-aminopropyl)benzofuran) and its N-methyl derivative 5-MAPB (N-methyl-5-(2-aminopropyl)benzofuran) are analogues of amphetamine and methamphetamine, respectively, and belong to the so-called novel psychoactive substances (NPS). They were consumed as stimulants or entactogens with euphoric and empathogenic effects. Being controlled in some countries, both compounds should be covered by drug testing in clinical and forensic toxicology. Therefore, metabolism studies have been performed by working up rat urine samples after a high single dose of the corresponding NPS with solid-phase extraction without and after enzymatic conjugates cleavage. The phase I metabolites were separated and identified after acetylation by GC-MS and/or LC-HR-MSn and the phase II metabolites by LC-HR-MSn. The main metabolite of 5-APB was 3-carboxymethyl-4-hydroxy amphetamine and the main metabolites of 5-MAPB were 5-APB (N-demethyl metabolite) and 3-carboxymethyl-4-hydroxy methamphetamine. The cytochrome P450 (CYP) isoenzymes involved in the 5-MAPB N-demethylation were CYP1A2, CYP2B6, CYP2C19, and CYP2D6, and according to the kinetic parameters, CYP2B6 was responsible for the main part of the total CYP-dependent clearance. An intake of a common users’ dose of 5-APB or 5-MAPB could be confirmed in rat urine using the authors’ GC-MS and the LC-MSn standard urine screening approaches with the corresponding parent drugs as major target. In authentic human urine samples after ingestion of unknown doses of 5-MAPB, both metabolites could also be detected besides the parent drug. The plasma concentrations determined in six clinical cases ranged from 5 to 124 μg/L for 5-MAPB and from 1 to 38 μg/L for its N-demethyl metabolite 5-APB.Keywords
This publication has 25 references indexed in Scilit:
- Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktailAnalytical and Bioanalytical Chemistry, 2014
- The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the ratProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2014
- 2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniquesAnalytical and Bioanalytical Chemistry, 2013
- Identification of (2-aminopropyl)benzofuran (APB) phenyl ring positional isomers in Internet purchased productsDrug Testing and Analysis, 2013
- Neurochemical profiles of some novel psychoactive substancesEuropean Journal of Pharmacology, 2013
- New cathinone‐derived designer drugs 3‐bromomethcathinone and 3‐fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC–MS and LC–high‐resolution MS and their detectability in urineJournal of Mass Spectrometry, 2012
- Development of the first metabolite-based LC-MS n urine drug screening procedure-exemplified for antidepressantsAnalytical and Bioanalytical Chemistry, 2010
- Automated Mass Spectral Deconvolution and Identification System for GC-MS Screening for Drugs, Poisons, and Metabolites in UrineClinical Chemistry, 2010
- The Impact of In Vitro Binding on In Vitro - In Vivo Extrapolations, Projections of Metabolic Clearance and Clinical Drug-Drug InteractionsCurrent Drug Metabolism, 2006
- The use of heterologously expressed drug metabolizing enzymes— state of the art and prospects for the futurePharmacology & Therapeutics, 1999